The Novel Predictive Biomarkers for Type 2 Diabetes Mellitus in Active Pulmonary Tuberculosis Patients

References

• World Health Organization. Global tuberculosis report 2021; 2021.
   Google Scholar
• Cui EN, Yu T, Shang S-J, et al. Radiomics model for distinguishing tuberculosis and lung cancer on computed tomography scans. World J Clin Cases. 2020;8(21):5203–5212. doi:10.12998/wjcc.v8.i21.5203
   PubMed Web of Science ®Google Scholar
• Fu X, Liu H, Liu J, et al. Association between triglyceride-glucose index and the risk of type 2 diabetes mellitus in an older Chinese population aged over 75 years. Front Public Health. 2021;9:796663. doi:10.3389/fpubh.2021.796663
   Web of Science ®Google Scholar
• Pan S-C, Ku C-C, Kao D, Ezzati M, Fang C-T, Lin -H-H. Effect of diabetes on tuberculosis control in 13 countries with high tuberculosis: a modelling study. Lancet Diabetes Endocrinol. 2015;3(5):323–330. doi:10.1016/S2213-8587(15)00042-X
   Web of Science ®Google Scholar
• Restrepo BI. Diabetes and tuberculosis. Microbiol Spectr. 2016;4(6). doi:10.1128/microbiolspec.TNMI7-0023-2016
   Web of Science ®Google Scholar
• Lontchi-Yimagou E, Sobngwi E, Matsha TE, Kengne AP. Diabetes mellitus and inflammation. Curr Diab Rep. 2013;13(3):435–444. doi:10.1007/s11892-013-0375-y
   PubMed Web of Science ®Google Scholar
• Calle MC, Fernandez ML. Inflammation and type 2 diabetes. Diabetes Metab. 2012;38(3):183–191. doi:10.1016/j.diabet.2011.11.006
   PubMed Web of Science ®Google Scholar
• Racanelli AC, Kikkers SA, Choi AMK, Cloonan SM. Autophagy and inflammation in chronic respiratory disease. Autophagy. 2018;14(2):221–232. doi:10.1080/15548627.2017.1389823
   PubMed Web of Science ®Google Scholar
• Pavan Kumar N, Nair D, Banurekha VV, et al. Type 2 diabetes mellitus coincident with pulmonary or latent tuberculosis results in modulation of adipocytokines. Cytokine. 2016;79:74–81. doi:10.1016/j.cyto.2015.12.026
   Web of Science ®Google Scholar
• Fernández RDV, Díaz A, Bongiovanni B, et al. Evidence for a more disrupted immune-endocrine relation and cortisol immunologic influences in the context of tuberculosis and type 2 diabetes comorbidity. Front Endocrinol (Lausanne). 2020;11:126. doi:10.3389/fendo.2020.00126
   Web of Science ®Google Scholar
• Webber T, Ronacher K, Conradie-Smit M, Kleynhans L. Interplay between the immune and endocrine systems in the lung: implications for TB susceptibility. Front Immunol. 2022;13:829355. doi:10.3389/fimmu.2022.829355
   Web of Science ®Google Scholar
• Usta A, Avci E, Bulbul CB, Kadi H, Adali E. The monocyte counts to HDL cholesterol ratio in obese and lean patients with polycystic ovary syndrome. Reprod Biol Endocrinol. 2018;16(1):34. doi:10.1186/s12958-018-0351-0
   Web of Science ®Google Scholar
• Soehnlein O, Steffens S, Hidalgo A, Weber C. Neutrophils as protagonists and targets in chronic inflammation. Nat Rev Immunol. 2017;17(4):248–261. doi:10.1038/nri.2017.10
   PubMed Web of Science ®Google Scholar
• Kurtul A, Yarlioglues M, Murat SN, et al. Usefulness of the platelet-to-lymphocyte ratio in predicting angiographic reflow after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction. Am J Cardiol. 2014;114(3):342–347. doi:10.1016/j.amjcard.2014.04.045
   PubMed Web of Science ®Google Scholar
• Cronkite DA, Strutt TM. The regulation of inflammation by innate and adaptive lymphocytes. J Immunol Res. 2018;2018:1467538. doi:10.1155/2018/1467538
   PubMed Web of Science ®Google Scholar
• Akboga MK, Balci KG, Maden O, et al. Usefulness of monocyte to HDL-cholesterol ratio to predict high SYNTAX score in patients with stable coronary artery disease. Biomark Med. 2016;10(4):375–383. doi:10.2217/bmm-2015-0050
   PubMed Web of Science ®Google Scholar
• Kreuter M, Lee JS, Tzouvelekis A, et al. Monocyte count as a prognostic biomarker in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2021;204(1):74–81. doi:10.1164/rccm.202003-0669OC
   PubMed Web of Science ®Google Scholar
• Jones TPW, Dabbaj S, Mandal I, et al. The blood neutrophil count after 1 month of treatment predicts the radiologic severity of lung disease at treatment end. Chest. 2021;160(6):2030–2041. doi:10.1016/j.chest.2021.07.041
   Web of Science ®Google Scholar
• Li L, Ma Y, Geng X-B, et al. Platelet-to-lymphocyte ratio relates to poor prognosis in elderly patients with acute myocardial infarction. Aging Clin Exp Res. 2021;33(3):619–624. doi:10.1007/s40520-020-01555-7
   PubMed Web of Science ®Google Scholar
• Karatas A, Turkmen E, Erdem E, Dugeroglu H, Kaya Y. Monocyte to high-density lipoprotein cholesterol ratio in patients with diabetes mellitus and diabetic nephropathy. Biomark Med. 2018;12(9):953–959. doi:10.2217/bmm-2018-0048
   PubMed Web of Science ®Google Scholar
• Wang S-Y, Shen -T-T, Xi B-L, Shen Z, Zhang X. Vitamin D affects the neutrophil-to-lymphocyte ratio in patients with type 2 diabetes mellitus. J Diabetes Investig. 2021;12(2):254–265. doi:10.1111/jdi.13338
   Web of Science ®Google Scholar
• Assulyn T, Khamisy-Farah R, Nseir W, Bashkin A, Farah R. Neutrophil-to-lymphocyte ratio and red blood cell distribution width as predictors of microalbuminuria in type 2 diabetes. J Clin Lab Anal. 2020;34(7):e23259. doi:10.1002/jcla.23259
   Web of Science ®Google Scholar
• Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001;286(3):327–334. doi:10.1001/jama.286.3.327
   PubMed Web of Science ®Google Scholar
• Cudahy PGT, Warren JL, Cohen T, Wilson D. Trends in C-reactive protein, D-dimer, and fibrinogen during therapy for HIV-associated multidrug-resistant tuberculosis. Am J Trop Med Hyg. 2018;99(5):1336–1341. doi:10.4269/ajtmh.18-0322
   PubMed Web of Science ®Google Scholar
• Cho AR, Lee S-B, Hong K-W, Jung D-H. C-reactive protein-to-albumin ratio and 8-year incidence of type 2 diabetes: the Korean genome and epidemiology study. Acta Diabetol. 2021;58(11):1525–1532. doi:10.1007/s00592-021-01755-1
   PubMed Web of Science ®Google Scholar
• Tolani S, Pagler TA, Murphy AJ, et al. Hypercholesterolemia and reduced HDL-C promote hematopoietic stem cell proliferation and monocytosis: studies in mice and FH children. Atherosclerosis. 2013;229(1):79–85. doi:10.1016/j.atherosclerosis.2013.03.031
   PubMed Web of Science ®Google Scholar
• Murphy AJ, Woollard KJ, Suhartoyo A, et al. Neutrophil activation is attenuated by high-density lipoprotein and apolipoprotein A-I in in vitro and in vivo models of inflammation. Arterioscler Thromb Vasc Biol. 2011;31(6):1333–1341. doi:10.1161/ATVBAHA.111.226258
   PubMed Web of Science ®Google Scholar
• Uslu AU, Sekin Y, Tarhan G, Canakcı N, Gunduz M, Karagulle M. Evaluation of monocyte to high-density lipoprotein cholesterol ratio in the presence and severity of metabolic syndrome. Clin Appl Thromb Hemost. 2018;24(5):828–833. doi:10.1177/1076029617741362
   PubMed Web of Science ®Google Scholar
• You S, Zhong C, Zheng D, et al. Monocyte to HDL cholesterol ratio is associated with discharge and 3-month outcome in patients with acute intracerebral hemorrhage. J Neurol Sci. 2017;372:157–161. doi:10.1016/j.jns.2016.11.022
   PubMed Web of Science ®Google Scholar
• Chen T, Chen H, Xiao H, et al. Comparison of the value of neutrophil to high-density lipoprotein cholesterol ratio and lymphocyte to high-density lipoprotein cholesterol ratio for predicting metabolic syndrome among a population in the Southern Coast of China. Diabetes Metab Syndr Obes. 2020;13:597–605. doi:10.2147/DMSO.S238990
   PubMed Web of Science ®Google Scholar
• Chen G, Yang N, Ren J, et al. Neutrophil counts to high-density lipoprotein cholesterol ratio: a potential predictor of prognosis in acute ischemic stroke patients after intravenous thrombolysis. Neurotox Res. 2020;38(4):1001–1009. doi:10.1007/s12640-020-00274-1
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang J, Li H, et al. Prognostic value of leucocyte to high-density lipoprotein-cholesterol ratios in COVID-19 patients and the diabetes subgroup. Front Endocrinol. 2021;12:727419. doi:10.3389/fendo.2021.727419
   Web of Science ®Google Scholar
• Taniai T, Haruki K, Hamura R, et al. The prognostic significance of C-reactive protein-to-lymphocyte ratio in colorectal liver metastases. J Surg Res. 2021;258:414–421. doi:10.1016/j.jss.2020.08.059
   Web of Science ®Google Scholar
• Tonduangu N, Le Borgne P, Lefebvre F, et al. Prognostic value of C-reactive protein to lymphocyte ratio (CLR) in emergency department patients with SARS-CoV-2 infection. J Pers Med. 2021;11(12):1274. doi:10.3390/jpm11121274
   Web of Science ®Google Scholar
• Koyuncu S, Ismail O. The role of C-reactive protein to lymphocyte ratio in the differentiation of acute and perforated appendicitis. Ulus Travma Acil Cerrahi Derg. 2020;26(5):760–764. doi:10.14744/tjtes.2020.47973
   Web of Science ®Google Scholar
• Frey A, Martin D, D’Cruz L, Fokas E, Rödel C, Fleischmann M. C-Reactive protein to albumin ratio as prognostic marker in locally advanced non-small cell lung cancer treated with chemoradiotherapy. Biomedicines. 2022;10(3):598. doi:10.3390/biomedicines10030598
   PubMed Web of Science ®Google Scholar
• Yang X, Yin H, Xiao C, Li R, Liu Y. The prognostic significance of C-reactive protein to albumin ratio in patients with severe fever with thrombocytopenia syndrome. Front Med. 2022;9:879982. doi:10.3389/fmed.2022.879982
   Web of Science ®Google Scholar
• Cheng L, Meng Z, Wang Q, et al. The usefulness of C-reactive protein to albumin ratio in the prediction of adverse cardiovascular events in coronary chronic total occlusion undergoing percutaneous coronary intervention. Front Cardiovasc Med. 2021;8:731261. doi:10.3389/fcvm.2021.731261
   PubMed Web of Science ®Google Scholar
• American Dietetic Association. Classification and diagnosis of diabetes. Diabetes Care. 2021;44(Suppl1):S15–S33. doi:10.2337/dc21-S002
   Web of Science ®Google Scholar
• Ca J, Bm M, Pinnelli VB, et al. The association of pulmonary tuberculosis, abnormal glucose tolerance, and type 2 diabetes mellitus: a hospital-based cross-sectional study. Cureus. 2021;13(11):e19758. doi:10.7759/cureus.19758
   Web of Science ®Google Scholar
• Prada-Medina CA, Fukutani KF, Pavan Kumar N, et al. Systems immunology of diabetes-tuberculosis comorbidity reveals signatures of disease complications. Sci Rep. 2017;7(1):1999. doi:10.1038/s41598-017-01767-4
   Web of Science ®Google Scholar
• Kumar NP, Sridhar R, Banurekha VV, et al. Type 2 diabetes mellitus coincident with pulmonary tuberculosis is associated with heightened systemic type 1, type 17, and other proinflammatory cytokines. Ann Am Thorac Soc. 2013;10(5):441–449. doi:10.1513/AnnalsATS.201305-112OC
   Google Scholar
• Onalan E. The relationship between monocyte to high-density lipoprotein cholesterol ratio and diabetic nephropathy. Pak J Med Sci. 2019;35(4):1081–1086. doi:10.12669/pjms.35.4.534
   PubMed Web of Science ®Google Scholar
• Vural G, Gümüsyayla Ş. Monocyte-to-high density lipoprotein ratio is associated with a decreased compound muscle action potential amplitude in patients with diabetic axonal polyneuropathy. Medicine. 2018;97(42):e12857. doi:10.1097/MD.0000000000012857
   Web of Science ®Google Scholar
• Hwang -J-J, Hur JY, Eo W, An S, Kim DH, Lee S. Clinical significance of C-reactive protein to lymphocyte count ratio as a prognostic factor for survival in non-small cell lung cancer patients undergoing curative surgical resection. J Cancer. 2021;12(15):4497–4504. doi:10.7150/jca.58094
   Web of Science ®Google Scholar
• Chiesa ST, Charakida M. High-density lipoprotein function and dysfunction in health and disease. Cardiovasc Drugs Ther. 2019;33(2):207–219. doi:10.1007/s10557-018-06846-w
   Web of Science ®Google Scholar
• Kautzky-Willer A, Harreiter J, Pacini G. Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus. Endocr Rev. 2016;37(3):278–316. doi:10.1210/er.2015-1137
   PubMed Web of Science ®Google Scholar
• Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047–1053. doi:10.2337/diacare.27.5.1047
   PubMed Web of Science ®Google Scholar
• Al-Sofiani ME, Ganji SS, Kalyani RR. Body composition changes in diabetes and aging. J Diabetes Complications. 2019;33(6):451–459. doi:10.1016/j.jdiacomp.2019.03.007
   PubMed Web of Science ®Google Scholar